← Back to BIAF

bioAffinity Technologies, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 11/05/2026Sep 2025Filed 14/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 11/05/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 15/05/2025
$1.5$1.4$1.4$1.3$1.9$2.4$2.4$2.4
−$3.4−$3.6−$5.1−$4.1−$2.7−$2−$2.1−$2
−$0.64−$0.81−$4.74−$5.07−$4.80−$4.84−$0.19−$0.20
5.24.51.1119.9

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.